ANXA6 and cancer: Overexpression of ANXA6 and accumulation of cholesterol in LEs could reduce cholesterol-sensitive cell mass formation, fibronectin (FN) secretion, and integrin recycling [18, 74, 75], and thereby reducing LDL-induced migration and invasion of hamster ovarian cells, and A431 cancer cells [45, 74, 76].